Osteoporosis, fracture risk, and prosthodontic implications.
Koka
Sreenivas
S
Division of Prosthodontics, Mayo Clinic, Rochester, Minnesota, USA. koka.sreenivas@mayo.edu
Salinas
Thomas J
TJ
Kennel
Kurt A
KA
D015519:Bone Density / Q000187:drug effects; D050071:Bone Density Conservation Agents / Q000009:adverse effects / Q000627:therapeutic use; D015921:Dental Implants; D004164:Diphosphonates / Q000009:adverse effects / Q000627:therapeutic use; D050723:Fractures, Bone / Q000209:etiology*; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced; D010020:Osteonecrosis / Q000139:chemically induced; D010024:Osteoporosis / Q000150:complications* / Q000517:prevention & control; D018570:Risk Assessment
D050071:Bone Density Conservation Agents; D015921:Dental Implants; D004164:Diphosphonates